Lyso-sphingomyelin is elevated in dried blood spots of Niemann-Pick B patients

Molecular Genetics and Metabolism

Volumn 111, Issue 2, 2014, Pages 209-211

  Chuang, Wei Lien ^a   Pacheco, Joshua ^a   Cooper, Samantha ^a   McGovern, Margaret M ^b   Cox, Gerald F ^a   Keutzer, Joan ^a   Zhang, X Kate ^a  

^a SANOFI   (France)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Dried blood spot; Lyso sphingomyelin; Niemann Pick disease types A and B; Sphingomyelin

Indexed keywords

SPHINGOMYELIN; SPHINGOSYLPHOSPHORYLCHOLINE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DEACETYLATION; DRIED BLOOD SPOT TESTING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ION MONITORING; MACROPHAGE; MASS SPECTROMETRY; MONOCYTE; NIEMANN PICK DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

DRIED BLOOD SPOT; LYSO-SPHINGOMYELIN; NIEMANN-PICK DISEASE TYPES A AND B; SPHINGOMYELIN;

BLOOD CELLS; CASE-CONTROL STUDIES; DRIED BLOOD SPOT TESTING; HUMANS; LYSOSOMES; MACROPHAGES; NIEMANN-PICK DISEASE, TYPE B; PHOSPHORYLCHOLINE; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE;

EID: 84893086797     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2013.11.012     Document Type: Article

References (23)

1. Schuchman E.H.a.D., R.J. Niemann-Pick disease types A and B: acid sphingomyelinase deficiencies. The Metabolic and Molecular Basis of Inherited Disease 2001, 3589-3610. McGraw-Hill, New York. B.A.L., C.R. Scriver, W.S. Sly, D. Valle (Eds.).
2. Vanier M.T. Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen. Biochim. Biophys. Acta 1983, 750:178-184.
3. Rodriguez-Lafrasse C., Vanier M.T. Sphingosylphosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not in type B. Neurochem. Res. 1999, 24:199-205.
4. McGovern M.M., Pohl-Worgall T., Deckelbaum R.J., Simpson W., Mendelson D., Desnick R.J., Schuchman E.H., Wasserstein M.P. Lipid abnormalities in children with types A and B Niemann Pick disease. J. Pediatr. 2004, 145:77-81.
5. Galbiati F., Givogri M.I., Cantuti L., Rosas A.L., Cao H., van Breemen R., Bongarzone E.R. Combined hematopoietic and lentiviral gene-transfer therapies in newborn Twitcher mice reveal contemporaneous neurodegeneration and demyelination in Krabbe disease. J. Neurosci. Res. 2009, 87:1748-1759.
6. Chuang W.L., Pacheco J., Zhang X.K., Martin M.M., Biski C.K., Keutzer J.M., Wenger D.A., Caggana M., Orsini J.J. Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease. Clin. Chim. Acta 2013, 419:73-76.
7. Aerts J.M., Groener J.E., Kuiper S., Donker-Koopman W.E., Strijland A., Ottenhoff R., van Roomen C., Mirzaian M., Wijburg F.A., Linthorst G.E., Vedder A.C., Rombach S.M., Cox-Brinkman J., Somerharju P., Boot R.G., Hollak C.E., Brady R.O., Poorthuis B.J. Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2812-2817.
8. Dekker N., van Dussen L., Hollak C.E., Overkleeft H., Scheij S., Ghauharali K., van Breemen M.J., Ferraz M.J., Groener J.E., Maas M., Wijburg F.A., Speijer D., Tylki-Szymanska A., Mistry P.K., Boot R.G., Aerts J.M. Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response. Blood 2011, 118:e118-e127.
9. Zhang X.K., Elbin C.S., Chuang W.L., Cooper S.K., Marashio C.A., Beauregard C., Keutzer J.M. Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry. Clin. Chem. 2008, 54:1725-1728.
10. He X., Chen F., Gatt S., Schuchman E.H. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease. Anal. Biochem. 2001, 293:204-211.
11. He X., Chen F., McGovern M.M., Schuchman E.H. A fluorescence-based, high-throughput sphingomyelin assay for the analysis of Niemann-Pick disease and other disorders of sphingomyelin metabolism. Anal. Biochem. 2002, 306:115-123.
12. Nixon G.F., Mathieson F.A., Hunter I. The multi-functional role of sphingosylphosphorylcholine. Prog. Lipid Res. 2008, 47:62-75.
13. Murata Y., Ogata J., Higaki Y., Kawashima M., Yada Y., Higuchi K., Tsuchiya T., Kawainami S., Imokawa G. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency?. J. Invest. Dermatol. 1996, 106:1242-1249.
14. Hara J., Higuchi K., Okamoto R., Kawashima M., Imokawa G. High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J. Invest. Dermatol. 2000, 115:406-413.
15. Fujino Y., Negishi T., Ito S. Enzymic synthesis of sphingosylphosphorylcholine. Biochem. J. 1968, 109:310-311.
16. Pentchev P.G., Brady R.O., Gal A.E., Hibbert S.R. The isolation and characterization of sphingomyelinase from human placental tissue. Biochim. Biophys. Acta 1977, 488:312-321.
17. Yamanaka T., Suzuki K. Acid sphingomyelinase of human brain: purification to homogeneity. J. Neurochem. 1982, 38:1753-1764.
18. Quintern L.E., Weitz G., Nehrkorn H., Tager J.M., Schram A.W., Sandhoff K. Acid sphingomyelinase from human urine: purification and characterization. Biochim. Biophys. Acta 1987, 922:323-336.
19. Tokumura A., Majima E., Kariya Y., Tominaga K., Kogure K., Yasuda K., Fukuzawa K. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 2002, 277:39436-39442.
20. Clair T., Aoki J., Koh E., Bandle R.W., Nam S.W., Ptaszynska M.M., Mills G.B., Schiffmann E., Liotta L.A., Stracke M.L. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res. 2003, 63:5446-5453.
21. Orvisky E., Park J.K., LaMarca M.E., Ginns E.I., Martin B.M., Tayebi N., Sidransky E. Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype. Mol. Genet. Metab. 2002, 76:262-270.
22. Nilsson O., Svennerholm L. Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J. Neurochem. 1982, 39:709-718.
23. Nofer J.R., Fobker M., Hobbel G., Voss R., Wolinska I., Tepel M., Zidek W., Junker R., Seedorf U., von Eckardstein A., Assmann G., Walter M. Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux. Biochemistry 2000, 39:15199-15207.